Even with treatment, patients with T2DM may face some troubles: spikes in blood glucose after meals, weight gain, a loss of effectiveness of their treatments over time etc. GLP-1 draws on a better understanding of how the body responds to meals—some already available and may offer useful adjuncts to existing therapies[42]. The gene discussed is GLP1R; the disease is type 2 diabetes mellitus.